TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. (Q50546790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Nazneen Fatima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Diane Lawson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

127-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21287692%20AND%20SRC:MED&resulttype=core&format=json

Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Bevacizumab in non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

Processing of pulmonary surfactant protein B by napsin and cathepsin H

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

21 January 2018

Pathology of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021

Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021

Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021

The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021

Pulmonary surfactant protein A in pleural effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021

Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20135

7 January 2021